Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporine A may help treat hair loss by blocking a protein that inhibits hair growth.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Dermoscopy improves diagnosis and treatment monitoring for children's skin infections, inflammations, and hair disorders.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Spironolactone helps regrow hair in women with hair loss.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Ice-skating athletes often have skin problems due to cold, infections, and inflammation, needing careful treatment and prevention.

Women with PMS tend to use suppression more, leading to higher stress levels.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

New alopecia treatments aim for better results and fewer side effects.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

The article concludes that advancements in hair cosmetics require dermatologists to stay informed about products and their potential risks, including allergies and higher risks for hairdressers.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.